Global Interventional Pulmonology Market
Global Interventional Pulmonology Market

Interventional Pulmonology Comprehensive Study by Type (Bronchoscopes, Electromagnetic Navigation Bronchoscopy Systems, Pleuroscopes, Respiratory Endotherapy Devices, Airway Stents, Pleural Catheters, Endobronchial Valves, Bronchial Thermoplasty Systems), End Users (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Specialty Clinics, Others), Indications (Asthma, COPD, Lung Cancer, Tracheal & Bronchial Stenosis, Recurrent respiratory papillomatosis, Relapsing Polychondritis, Tracheomalacia, Tuberculosis, Others) Players and Region - Global Market Outlook to 2026

Interventional Pulmonology Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Jun 2021 Edition 212 Pages 192 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Interventional Pulmonology Market Overview:
Interventional pulmonology is comparatively new in the field of pulmonary medicine. Interventional pulmonology used endoscopy and other various tools to diagnose and treat conditions in the lungs and chest. These procedures are majorly delivered by lung specialists. Interventional pulmonology is a relatively promising but quickly growing subspecialty across the United States. As the United States is primarily focused on advanced diagnostic and therapeutic procedures involving the airways, lungs, and pleura. Some of the players profiled in the study are Argon Medical (United States), Body Vision Medical Ltd. (Israel), Boston Scientific Corporation (United States), C. R. Bard, Inc. (Becton, Dickinson and Company) (United States), CONMED Corporation (United States), ENDO-FLEX GmbH (Germany), Fujifilm Corporation (Japan), KARL STORZ SE & Co. KG (Germany), Medtronic (Ireland) and Olympus Corporation (Japan).

On the basis of geography, the market of Interventional Pulmonology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2020. If we see Market by End Users, the sub-segment i.e. Hospitals will boost the Interventional Pulmonology market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Indications, the sub-segment i.e. Asthma will boost the Interventional Pulmonology market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Growth Drivers
  • Increase Occurrence of Respiratory Disorders across the Globe

Influencing Trend
  • Robotic Bronchoscopy is Emerging as a Game Changer in the Interventional Pulmonology Market

Restraints
  • Lack of Awareness

Opportunities
  • Strategic Acquisitions Help Expand Respiratory Portfolio, Accelerate Medical Processes

Challenges
  • Increase Concern Related to the Increasing Side Effects Concern Such as Bleeding, and Others




The Service Providers are operating in the market are exploring their footprint in new geographical regions and also heavily investing in business growth strategies such as mergers & acquisitions, expansions, investments, new service launches, and others. The market key players are exploring new market opportunity areas through expansions and acquisitions across the globe to avail a competitive advantage through combined synergies.

Target Audience:
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Interventional Pulmonology Manufacturers, Suppliers and Distributors, Raw Material Suppliers, Government Regulatory and Research Organizations and End-Use Industries

Major Objectives Focused through this Study
• To define, describe, and forecast the Global Interventional Pulmonology market on the basis of product [Bronchoscopes, Electromagnetic Navigation Bronchoscopy Systems, Pleuroscopes, Respiratory Endotherapy Devices, Airway Stents, Pleural Catheters, Endobronchial Valves and Bronchial Thermoplasty Systems] , application [], key regions and end user
• To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
• To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
• Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
• To provide market size for various segments of the Interventional Pulmonology market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
• To strategically profile the key players and analyzing their market shares and core competencies in the Interventional Pulmonology industry
• To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are Pennine Healthcare (United Kingdom), PENTAX Medical (Japan) and Pulmonx Corporation (United States).
** Confirmation on availability of data would be informed prior purchase

While framing the research framework, major and emerging players operating in the Interventional Pulmonology market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.
Report Objectives / Segmentation Covered
By Type
  • Bronchoscopes
  • Electromagnetic Navigation Bronchoscopy Systems
  • Pleuroscopes
  • Respiratory Endotherapy Devices
  • Airway Stents
  • Pleural Catheters
  • Endobronchial Valves
  • Bronchial Thermoplasty Systems
By End Users
  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Specialty Clinics
  • Others

By Indications
  • Asthma
  • COPD
  • Lung Cancer
  • Tracheal & Bronchial Stenosis
  • Recurrent respiratory papillomatosis
  • Relapsing Polychondritis
  • Tracheomalacia
  • Tuberculosis
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase Occurrence of Respiratory Disorders across the Globe
    • 3.3. Market Challenges
      • 3.3.1. Increase Concern Related to the Increasing Side Effects Concern Such as Bleeding, and Others
    • 3.4. Market Trends
      • 3.4.1. Robotic Bronchoscopy is Emerging as a Game Changer in the Interventional Pulmonology Market
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Interventional Pulmonology, by Type, End Users, Indications and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Interventional Pulmonology (Value)
      • 5.2.1. Global Interventional Pulmonology by: Type (Value)
        • 5.2.1.1. Bronchoscopes
        • 5.2.1.2. Electromagnetic Navigation Bronchoscopy Systems
        • 5.2.1.3. Pleuroscopes
        • 5.2.1.4. Respiratory Endotherapy Devices
        • 5.2.1.5. Airway Stents
        • 5.2.1.6. Pleural Catheters
        • 5.2.1.7. Endobronchial Valves
        • 5.2.1.8. Bronchial Thermoplasty Systems
      • 5.2.2. Global Interventional Pulmonology by: End Users (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Ambulatory Surgical Centers
        • 5.2.2.3. Diagnostic Centers
        • 5.2.2.4. Specialty Clinics
        • 5.2.2.5. Others
      • 5.2.3. Global Interventional Pulmonology by: Indications (Value)
        • 5.2.3.1. Asthma
        • 5.2.3.2. COPD
        • 5.2.3.3. Lung Cancer
        • 5.2.3.4. Tracheal & Bronchial Stenosis
        • 5.2.3.5. Recurrent respiratory papillomatosis
        • 5.2.3.6. Relapsing Polychondritis
        • 5.2.3.7. Tracheomalacia
        • 5.2.3.8. Tuberculosis
        • 5.2.3.9. Others
      • 5.2.4. Global Interventional Pulmonology Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Interventional Pulmonology (Price)
      • 5.3.1. Global Interventional Pulmonology by: Type (Price)
  • 6. Interventional Pulmonology: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Argon Medical (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Body Vision Medical Ltd. (Israel)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Boston Scientific Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. C. R. Bard, Inc. (Becton, Dickinson and Company) (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. CONMED Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. ENDO-FLEX GmbH (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Fujifilm Corporation (Japan)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. KARL STORZ SE & Co. KG (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Medtronic (Ireland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Olympus Corporation (Japan)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Interventional Pulmonology Sale, by Type, End Users, Indications and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Interventional Pulmonology (Value)
      • 7.2.1. Global Interventional Pulmonology by: Type (Value)
        • 7.2.1.1. Bronchoscopes
        • 7.2.1.2. Electromagnetic Navigation Bronchoscopy Systems
        • 7.2.1.3. Pleuroscopes
        • 7.2.1.4. Respiratory Endotherapy Devices
        • 7.2.1.5. Airway Stents
        • 7.2.1.6. Pleural Catheters
        • 7.2.1.7. Endobronchial Valves
        • 7.2.1.8. Bronchial Thermoplasty Systems
      • 7.2.2. Global Interventional Pulmonology by: End Users (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Ambulatory Surgical Centers
        • 7.2.2.3. Diagnostic Centers
        • 7.2.2.4. Specialty Clinics
        • 7.2.2.5. Others
      • 7.2.3. Global Interventional Pulmonology by: Indications (Value)
        • 7.2.3.1. Asthma
        • 7.2.3.2. COPD
        • 7.2.3.3. Lung Cancer
        • 7.2.3.4. Tracheal & Bronchial Stenosis
        • 7.2.3.5. Recurrent respiratory papillomatosis
        • 7.2.3.6. Relapsing Polychondritis
        • 7.2.3.7. Tracheomalacia
        • 7.2.3.8. Tuberculosis
        • 7.2.3.9. Others
      • 7.2.4. Global Interventional Pulmonology Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Interventional Pulmonology (Price)
      • 7.3.1. Global Interventional Pulmonology by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Interventional Pulmonology: by Type(USD Million)
  • Table 2. Interventional Pulmonology Bronchoscopes , by Region USD Million (2015-2020)
  • Table 3. Interventional Pulmonology Electromagnetic Navigation Bronchoscopy Systems , by Region USD Million (2015-2020)
  • Table 4. Interventional Pulmonology Pleuroscopes , by Region USD Million (2015-2020)
  • Table 5. Interventional Pulmonology Respiratory Endotherapy Devices , by Region USD Million (2015-2020)
  • Table 6. Interventional Pulmonology Airway Stents , by Region USD Million (2015-2020)
  • Table 7. Interventional Pulmonology Pleural Catheters , by Region USD Million (2015-2020)
  • Table 8. Interventional Pulmonology Endobronchial Valves , by Region USD Million (2015-2020)
  • Table 9. Interventional Pulmonology Bronchial Thermoplasty Systems , by Region USD Million (2015-2020)
  • Table 10. Interventional Pulmonology: by End Users(USD Million)
  • Table 11. Interventional Pulmonology Hospitals , by Region USD Million (2015-2020)
  • Table 12. Interventional Pulmonology Ambulatory Surgical Centers , by Region USD Million (2015-2020)
  • Table 13. Interventional Pulmonology Diagnostic Centers , by Region USD Million (2015-2020)
  • Table 14. Interventional Pulmonology Specialty Clinics , by Region USD Million (2015-2020)
  • Table 15. Interventional Pulmonology Others , by Region USD Million (2015-2020)
  • Table 16. Interventional Pulmonology: by Indications(USD Million)
  • Table 17. Interventional Pulmonology Asthma , by Region USD Million (2015-2020)
  • Table 18. Interventional Pulmonology COPD , by Region USD Million (2015-2020)
  • Table 19. Interventional Pulmonology Lung Cancer , by Region USD Million (2015-2020)
  • Table 20. Interventional Pulmonology Tracheal & Bronchial Stenosis , by Region USD Million (2015-2020)
  • Table 21. Interventional Pulmonology Recurrent respiratory papillomatosis , by Region USD Million (2015-2020)
  • Table 22. Interventional Pulmonology Relapsing Polychondritis , by Region USD Million (2015-2020)
  • Table 23. Interventional Pulmonology Tracheomalacia , by Region USD Million (2015-2020)
  • Table 24. Interventional Pulmonology Tuberculosis , by Region USD Million (2015-2020)
  • Table 25. Interventional Pulmonology Others , by Region USD Million (2015-2020)
  • Table 26. South America Interventional Pulmonology, by Country USD Million (2015-2020)
  • Table 27. South America Interventional Pulmonology, by Type USD Million (2015-2020)
  • Table 28. South America Interventional Pulmonology, by End Users USD Million (2015-2020)
  • Table 29. South America Interventional Pulmonology, by Indications USD Million (2015-2020)
  • Table 30. Brazil Interventional Pulmonology, by Type USD Million (2015-2020)
  • Table 31. Brazil Interventional Pulmonology, by End Users USD Million (2015-2020)
  • Table 32. Brazil Interventional Pulmonology, by Indications USD Million (2015-2020)
  • Table 33. Argentina Interventional Pulmonology, by Type USD Million (2015-2020)
  • Table 34. Argentina Interventional Pulmonology, by End Users USD Million (2015-2020)
  • Table 35. Argentina Interventional Pulmonology, by Indications USD Million (2015-2020)
  • Table 36. Rest of South America Interventional Pulmonology, by Type USD Million (2015-2020)
  • Table 37. Rest of South America Interventional Pulmonology, by End Users USD Million (2015-2020)
  • Table 38. Rest of South America Interventional Pulmonology, by Indications USD Million (2015-2020)
  • Table 39. Asia Pacific Interventional Pulmonology, by Country USD Million (2015-2020)
  • Table 40. Asia Pacific Interventional Pulmonology, by Type USD Million (2015-2020)
  • Table 41. Asia Pacific Interventional Pulmonology, by End Users USD Million (2015-2020)
  • Table 42. Asia Pacific Interventional Pulmonology, by Indications USD Million (2015-2020)
  • Table 43. China Interventional Pulmonology, by Type USD Million (2015-2020)
  • Table 44. China Interventional Pulmonology, by End Users USD Million (2015-2020)
  • Table 45. China Interventional Pulmonology, by Indications USD Million (2015-2020)
  • Table 46. Japan Interventional Pulmonology, by Type USD Million (2015-2020)
  • Table 47. Japan Interventional Pulmonology, by End Users USD Million (2015-2020)
  • Table 48. Japan Interventional Pulmonology, by Indications USD Million (2015-2020)
  • Table 49. India Interventional Pulmonology, by Type USD Million (2015-2020)
  • Table 50. India Interventional Pulmonology, by End Users USD Million (2015-2020)
  • Table 51. India Interventional Pulmonology, by Indications USD Million (2015-2020)
  • Table 52. South Korea Interventional Pulmonology, by Type USD Million (2015-2020)
  • Table 53. South Korea Interventional Pulmonology, by End Users USD Million (2015-2020)
  • Table 54. South Korea Interventional Pulmonology, by Indications USD Million (2015-2020)
  • Table 55. Taiwan Interventional Pulmonology, by Type USD Million (2015-2020)
  • Table 56. Taiwan Interventional Pulmonology, by End Users USD Million (2015-2020)
  • Table 57. Taiwan Interventional Pulmonology, by Indications USD Million (2015-2020)
  • Table 58. Australia Interventional Pulmonology, by Type USD Million (2015-2020)
  • Table 59. Australia Interventional Pulmonology, by End Users USD Million (2015-2020)
  • Table 60. Australia Interventional Pulmonology, by Indications USD Million (2015-2020)
  • Table 61. Rest of Asia-Pacific Interventional Pulmonology, by Type USD Million (2015-2020)
  • Table 62. Rest of Asia-Pacific Interventional Pulmonology, by End Users USD Million (2015-2020)
  • Table 63. Rest of Asia-Pacific Interventional Pulmonology, by Indications USD Million (2015-2020)
  • Table 64. Europe Interventional Pulmonology, by Country USD Million (2015-2020)
  • Table 65. Europe Interventional Pulmonology, by Type USD Million (2015-2020)
  • Table 66. Europe Interventional Pulmonology, by End Users USD Million (2015-2020)
  • Table 67. Europe Interventional Pulmonology, by Indications USD Million (2015-2020)
  • Table 68. Germany Interventional Pulmonology, by Type USD Million (2015-2020)
  • Table 69. Germany Interventional Pulmonology, by End Users USD Million (2015-2020)
  • Table 70. Germany Interventional Pulmonology, by Indications USD Million (2015-2020)
  • Table 71. France Interventional Pulmonology, by Type USD Million (2015-2020)
  • Table 72. France Interventional Pulmonology, by End Users USD Million (2015-2020)
  • Table 73. France Interventional Pulmonology, by Indications USD Million (2015-2020)
  • Table 74. Italy Interventional Pulmonology, by Type USD Million (2015-2020)
  • Table 75. Italy Interventional Pulmonology, by End Users USD Million (2015-2020)
  • Table 76. Italy Interventional Pulmonology, by Indications USD Million (2015-2020)
  • Table 77. United Kingdom Interventional Pulmonology, by Type USD Million (2015-2020)
  • Table 78. United Kingdom Interventional Pulmonology, by End Users USD Million (2015-2020)
  • Table 79. United Kingdom Interventional Pulmonology, by Indications USD Million (2015-2020)
  • Table 80. Netherlands Interventional Pulmonology, by Type USD Million (2015-2020)
  • Table 81. Netherlands Interventional Pulmonology, by End Users USD Million (2015-2020)
  • Table 82. Netherlands Interventional Pulmonology, by Indications USD Million (2015-2020)
  • Table 83. Rest of Europe Interventional Pulmonology, by Type USD Million (2015-2020)
  • Table 84. Rest of Europe Interventional Pulmonology, by End Users USD Million (2015-2020)
  • Table 85. Rest of Europe Interventional Pulmonology, by Indications USD Million (2015-2020)
  • Table 86. MEA Interventional Pulmonology, by Country USD Million (2015-2020)
  • Table 87. MEA Interventional Pulmonology, by Type USD Million (2015-2020)
  • Table 88. MEA Interventional Pulmonology, by End Users USD Million (2015-2020)
  • Table 89. MEA Interventional Pulmonology, by Indications USD Million (2015-2020)
  • Table 90. Middle East Interventional Pulmonology, by Type USD Million (2015-2020)
  • Table 91. Middle East Interventional Pulmonology, by End Users USD Million (2015-2020)
  • Table 92. Middle East Interventional Pulmonology, by Indications USD Million (2015-2020)
  • Table 93. Africa Interventional Pulmonology, by Type USD Million (2015-2020)
  • Table 94. Africa Interventional Pulmonology, by End Users USD Million (2015-2020)
  • Table 95. Africa Interventional Pulmonology, by Indications USD Million (2015-2020)
  • Table 96. North America Interventional Pulmonology, by Country USD Million (2015-2020)
  • Table 97. North America Interventional Pulmonology, by Type USD Million (2015-2020)
  • Table 98. North America Interventional Pulmonology, by End Users USD Million (2015-2020)
  • Table 99. North America Interventional Pulmonology, by Indications USD Million (2015-2020)
  • Table 100. United States Interventional Pulmonology, by Type USD Million (2015-2020)
  • Table 101. United States Interventional Pulmonology, by End Users USD Million (2015-2020)
  • Table 102. United States Interventional Pulmonology, by Indications USD Million (2015-2020)
  • Table 103. Canada Interventional Pulmonology, by Type USD Million (2015-2020)
  • Table 104. Canada Interventional Pulmonology, by End Users USD Million (2015-2020)
  • Table 105. Canada Interventional Pulmonology, by Indications USD Million (2015-2020)
  • Table 106. Mexico Interventional Pulmonology, by Type USD Million (2015-2020)
  • Table 107. Mexico Interventional Pulmonology, by End Users USD Million (2015-2020)
  • Table 108. Mexico Interventional Pulmonology, by Indications USD Million (2015-2020)
  • Table 109. Interventional Pulmonology: by Type(USD/Units)
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Company Basic Information, Sales Area and Its Competitors
  • Table 115. Company Basic Information, Sales Area and Its Competitors
  • Table 116. Company Basic Information, Sales Area and Its Competitors
  • Table 117. Company Basic Information, Sales Area and Its Competitors
  • Table 118. Company Basic Information, Sales Area and Its Competitors
  • Table 119. Company Basic Information, Sales Area and Its Competitors
  • Table 120. Interventional Pulmonology: by Type(USD Million)
  • Table 121. Interventional Pulmonology Bronchoscopes , by Region USD Million (2021-2026)
  • Table 122. Interventional Pulmonology Electromagnetic Navigation Bronchoscopy Systems , by Region USD Million (2021-2026)
  • Table 123. Interventional Pulmonology Pleuroscopes , by Region USD Million (2021-2026)
  • Table 124. Interventional Pulmonology Respiratory Endotherapy Devices , by Region USD Million (2021-2026)
  • Table 125. Interventional Pulmonology Airway Stents , by Region USD Million (2021-2026)
  • Table 126. Interventional Pulmonology Pleural Catheters , by Region USD Million (2021-2026)
  • Table 127. Interventional Pulmonology Endobronchial Valves , by Region USD Million (2021-2026)
  • Table 128. Interventional Pulmonology Bronchial Thermoplasty Systems , by Region USD Million (2021-2026)
  • Table 129. Interventional Pulmonology: by End Users(USD Million)
  • Table 130. Interventional Pulmonology Hospitals , by Region USD Million (2021-2026)
  • Table 131. Interventional Pulmonology Ambulatory Surgical Centers , by Region USD Million (2021-2026)
  • Table 132. Interventional Pulmonology Diagnostic Centers , by Region USD Million (2021-2026)
  • Table 133. Interventional Pulmonology Specialty Clinics , by Region USD Million (2021-2026)
  • Table 134. Interventional Pulmonology Others , by Region USD Million (2021-2026)
  • Table 135. Interventional Pulmonology: by Indications(USD Million)
  • Table 136. Interventional Pulmonology Asthma , by Region USD Million (2021-2026)
  • Table 137. Interventional Pulmonology COPD , by Region USD Million (2021-2026)
  • Table 138. Interventional Pulmonology Lung Cancer , by Region USD Million (2021-2026)
  • Table 139. Interventional Pulmonology Tracheal & Bronchial Stenosis , by Region USD Million (2021-2026)
  • Table 140. Interventional Pulmonology Recurrent respiratory papillomatosis , by Region USD Million (2021-2026)
  • Table 141. Interventional Pulmonology Relapsing Polychondritis , by Region USD Million (2021-2026)
  • Table 142. Interventional Pulmonology Tracheomalacia , by Region USD Million (2021-2026)
  • Table 143. Interventional Pulmonology Tuberculosis , by Region USD Million (2021-2026)
  • Table 144. Interventional Pulmonology Others , by Region USD Million (2021-2026)
  • Table 145. South America Interventional Pulmonology, by Country USD Million (2021-2026)
  • Table 146. South America Interventional Pulmonology, by Type USD Million (2021-2026)
  • Table 147. South America Interventional Pulmonology, by End Users USD Million (2021-2026)
  • Table 148. South America Interventional Pulmonology, by Indications USD Million (2021-2026)
  • Table 149. Brazil Interventional Pulmonology, by Type USD Million (2021-2026)
  • Table 150. Brazil Interventional Pulmonology, by End Users USD Million (2021-2026)
  • Table 151. Brazil Interventional Pulmonology, by Indications USD Million (2021-2026)
  • Table 152. Argentina Interventional Pulmonology, by Type USD Million (2021-2026)
  • Table 153. Argentina Interventional Pulmonology, by End Users USD Million (2021-2026)
  • Table 154. Argentina Interventional Pulmonology, by Indications USD Million (2021-2026)
  • Table 155. Rest of South America Interventional Pulmonology, by Type USD Million (2021-2026)
  • Table 156. Rest of South America Interventional Pulmonology, by End Users USD Million (2021-2026)
  • Table 157. Rest of South America Interventional Pulmonology, by Indications USD Million (2021-2026)
  • Table 158. Asia Pacific Interventional Pulmonology, by Country USD Million (2021-2026)
  • Table 159. Asia Pacific Interventional Pulmonology, by Type USD Million (2021-2026)
  • Table 160. Asia Pacific Interventional Pulmonology, by End Users USD Million (2021-2026)
  • Table 161. Asia Pacific Interventional Pulmonology, by Indications USD Million (2021-2026)
  • Table 162. China Interventional Pulmonology, by Type USD Million (2021-2026)
  • Table 163. China Interventional Pulmonology, by End Users USD Million (2021-2026)
  • Table 164. China Interventional Pulmonology, by Indications USD Million (2021-2026)
  • Table 165. Japan Interventional Pulmonology, by Type USD Million (2021-2026)
  • Table 166. Japan Interventional Pulmonology, by End Users USD Million (2021-2026)
  • Table 167. Japan Interventional Pulmonology, by Indications USD Million (2021-2026)
  • Table 168. India Interventional Pulmonology, by Type USD Million (2021-2026)
  • Table 169. India Interventional Pulmonology, by End Users USD Million (2021-2026)
  • Table 170. India Interventional Pulmonology, by Indications USD Million (2021-2026)
  • Table 171. South Korea Interventional Pulmonology, by Type USD Million (2021-2026)
  • Table 172. South Korea Interventional Pulmonology, by End Users USD Million (2021-2026)
  • Table 173. South Korea Interventional Pulmonology, by Indications USD Million (2021-2026)
  • Table 174. Taiwan Interventional Pulmonology, by Type USD Million (2021-2026)
  • Table 175. Taiwan Interventional Pulmonology, by End Users USD Million (2021-2026)
  • Table 176. Taiwan Interventional Pulmonology, by Indications USD Million (2021-2026)
  • Table 177. Australia Interventional Pulmonology, by Type USD Million (2021-2026)
  • Table 178. Australia Interventional Pulmonology, by End Users USD Million (2021-2026)
  • Table 179. Australia Interventional Pulmonology, by Indications USD Million (2021-2026)
  • Table 180. Rest of Asia-Pacific Interventional Pulmonology, by Type USD Million (2021-2026)
  • Table 181. Rest of Asia-Pacific Interventional Pulmonology, by End Users USD Million (2021-2026)
  • Table 182. Rest of Asia-Pacific Interventional Pulmonology, by Indications USD Million (2021-2026)
  • Table 183. Europe Interventional Pulmonology, by Country USD Million (2021-2026)
  • Table 184. Europe Interventional Pulmonology, by Type USD Million (2021-2026)
  • Table 185. Europe Interventional Pulmonology, by End Users USD Million (2021-2026)
  • Table 186. Europe Interventional Pulmonology, by Indications USD Million (2021-2026)
  • Table 187. Germany Interventional Pulmonology, by Type USD Million (2021-2026)
  • Table 188. Germany Interventional Pulmonology, by End Users USD Million (2021-2026)
  • Table 189. Germany Interventional Pulmonology, by Indications USD Million (2021-2026)
  • Table 190. France Interventional Pulmonology, by Type USD Million (2021-2026)
  • Table 191. France Interventional Pulmonology, by End Users USD Million (2021-2026)
  • Table 192. France Interventional Pulmonology, by Indications USD Million (2021-2026)
  • Table 193. Italy Interventional Pulmonology, by Type USD Million (2021-2026)
  • Table 194. Italy Interventional Pulmonology, by End Users USD Million (2021-2026)
  • Table 195. Italy Interventional Pulmonology, by Indications USD Million (2021-2026)
  • Table 196. United Kingdom Interventional Pulmonology, by Type USD Million (2021-2026)
  • Table 197. United Kingdom Interventional Pulmonology, by End Users USD Million (2021-2026)
  • Table 198. United Kingdom Interventional Pulmonology, by Indications USD Million (2021-2026)
  • Table 199. Netherlands Interventional Pulmonology, by Type USD Million (2021-2026)
  • Table 200. Netherlands Interventional Pulmonology, by End Users USD Million (2021-2026)
  • Table 201. Netherlands Interventional Pulmonology, by Indications USD Million (2021-2026)
  • Table 202. Rest of Europe Interventional Pulmonology, by Type USD Million (2021-2026)
  • Table 203. Rest of Europe Interventional Pulmonology, by End Users USD Million (2021-2026)
  • Table 204. Rest of Europe Interventional Pulmonology, by Indications USD Million (2021-2026)
  • Table 205. MEA Interventional Pulmonology, by Country USD Million (2021-2026)
  • Table 206. MEA Interventional Pulmonology, by Type USD Million (2021-2026)
  • Table 207. MEA Interventional Pulmonology, by End Users USD Million (2021-2026)
  • Table 208. MEA Interventional Pulmonology, by Indications USD Million (2021-2026)
  • Table 209. Middle East Interventional Pulmonology, by Type USD Million (2021-2026)
  • Table 210. Middle East Interventional Pulmonology, by End Users USD Million (2021-2026)
  • Table 211. Middle East Interventional Pulmonology, by Indications USD Million (2021-2026)
  • Table 212. Africa Interventional Pulmonology, by Type USD Million (2021-2026)
  • Table 213. Africa Interventional Pulmonology, by End Users USD Million (2021-2026)
  • Table 214. Africa Interventional Pulmonology, by Indications USD Million (2021-2026)
  • Table 215. North America Interventional Pulmonology, by Country USD Million (2021-2026)
  • Table 216. North America Interventional Pulmonology, by Type USD Million (2021-2026)
  • Table 217. North America Interventional Pulmonology, by End Users USD Million (2021-2026)
  • Table 218. North America Interventional Pulmonology, by Indications USD Million (2021-2026)
  • Table 219. United States Interventional Pulmonology, by Type USD Million (2021-2026)
  • Table 220. United States Interventional Pulmonology, by End Users USD Million (2021-2026)
  • Table 221. United States Interventional Pulmonology, by Indications USD Million (2021-2026)
  • Table 222. Canada Interventional Pulmonology, by Type USD Million (2021-2026)
  • Table 223. Canada Interventional Pulmonology, by End Users USD Million (2021-2026)
  • Table 224. Canada Interventional Pulmonology, by Indications USD Million (2021-2026)
  • Table 225. Mexico Interventional Pulmonology, by Type USD Million (2021-2026)
  • Table 226. Mexico Interventional Pulmonology, by End Users USD Million (2021-2026)
  • Table 227. Mexico Interventional Pulmonology, by Indications USD Million (2021-2026)
  • Table 228. Interventional Pulmonology: by Type(USD/Units)
  • Table 229. Research Programs/Design for This Report
  • Table 230. Key Data Information from Secondary Sources
  • Table 231. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Interventional Pulmonology: by Type USD Million (2015-2020)
  • Figure 5. Global Interventional Pulmonology: by End Users USD Million (2015-2020)
  • Figure 6. Global Interventional Pulmonology: by Indications USD Million (2015-2020)
  • Figure 7. South America Interventional Pulmonology Share (%), by Country
  • Figure 8. Asia Pacific Interventional Pulmonology Share (%), by Country
  • Figure 9. Europe Interventional Pulmonology Share (%), by Country
  • Figure 10. MEA Interventional Pulmonology Share (%), by Country
  • Figure 11. North America Interventional Pulmonology Share (%), by Country
  • Figure 12. Global Interventional Pulmonology: by Type USD/Units (2015-2020)
  • Figure 13. Global Interventional Pulmonology share by Players 2020 (%)
  • Figure 14. Global Interventional Pulmonology share by Players (Top 3) 2020(%)
  • Figure 15. Global Interventional Pulmonology share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Argon Medical (United States) Revenue, Net Income and Gross profit
  • Figure 18. Argon Medical (United States) Revenue: by Geography 2020
  • Figure 19. Body Vision Medical Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 20. Body Vision Medical Ltd. (Israel) Revenue: by Geography 2020
  • Figure 21. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 22. Boston Scientific Corporation (United States) Revenue: by Geography 2020
  • Figure 23. C. R. Bard, Inc. (Becton, Dickinson and Company) (United States) Revenue, Net Income and Gross profit
  • Figure 24. C. R. Bard, Inc. (Becton, Dickinson and Company) (United States) Revenue: by Geography 2020
  • Figure 25. CONMED Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 26. CONMED Corporation (United States) Revenue: by Geography 2020
  • Figure 27. ENDO-FLEX GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 28. ENDO-FLEX GmbH (Germany) Revenue: by Geography 2020
  • Figure 29. Fujifilm Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 30. Fujifilm Corporation (Japan) Revenue: by Geography 2020
  • Figure 31. KARL STORZ SE & Co. KG (Germany) Revenue, Net Income and Gross profit
  • Figure 32. KARL STORZ SE & Co. KG (Germany) Revenue: by Geography 2020
  • Figure 33. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 34. Medtronic (Ireland) Revenue: by Geography 2020
  • Figure 35. Olympus Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 36. Olympus Corporation (Japan) Revenue: by Geography 2020
  • Figure 37. Global Interventional Pulmonology: by Type USD Million (2021-2026)
  • Figure 38. Global Interventional Pulmonology: by End Users USD Million (2021-2026)
  • Figure 39. Global Interventional Pulmonology: by Indications USD Million (2021-2026)
  • Figure 40. South America Interventional Pulmonology Share (%), by Country
  • Figure 41. Asia Pacific Interventional Pulmonology Share (%), by Country
  • Figure 42. Europe Interventional Pulmonology Share (%), by Country
  • Figure 43. MEA Interventional Pulmonology Share (%), by Country
  • Figure 44. North America Interventional Pulmonology Share (%), by Country
  • Figure 45. Global Interventional Pulmonology: by Type USD/Units (2021-2026)
Some of the key companies/manufacturers profiled in the report
  • Argon Medical (United States)
  • Body Vision Medical Ltd. (Israel)
  • Boston Scientific Corporation (United States)
  • C. R. Bard, Inc. (Becton, Dickinson and Company) (United States)
  • CONMED Corporation (United States)
  • ENDO-FLEX GmbH (Germany)
  • Fujifilm Corporation (Japan)
  • KARL STORZ SE & Co. KG (Germany)
  • Medtronic (Ireland)
  • Olympus Corporation (Japan)
Additional players considered in the study are as follows:
Pennine Healthcare (United Kingdom) , PENTAX Medical (Japan) , Pulmonx Corporation (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation